舍曲林与三环类抗抑郁药之间的相互作用。 - Suppr

Suppr

超能文献

Interactions between sertraline and tricyclic antidepressants.

作者信息

Lydiard R B, Anton R F, Cunningham T

出版信息

Am J Psychiatry. 1993 Jul;150(7):1125-6. doi: 10.1176/ajp.150.7.1125b.

DOI:10.1176/ajp.150.7.1125b

PMID:8317590

Abstract

摘要

相似文献

Interactions between sertraline and tricyclic antidepressants.

Am J Psychiatry. 1993 Jul;150(7):1125-6. doi: 10.1176/ajp.150.7.1125b.

An interaction of sertraline and desipramine.

Am J Psychiatry. 1993 Nov;150(11):1751. doi: 10.1176/ajp.150.11.1751a.

The effect of sertraline on the pharmacokinetics of desipramine and imipramine.

Clin Pharmacol Ther. 1997 Aug;62(2):145-56. doi: 10.1016/S0009-9236(97)90062-X.

Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.

Br J Clin Pharmacol. 1997 Jun;43(6):619-26. doi: 10.1046/j.1365-2125.1997.00591.x.

Drug-drug interactions.

J Clin Psychiatry. 1996 May;57(5):223-7.

Reducing the risk of drug-drug interactions: a goal of rational drug development.

J Clin Psychiatry. 1996;57 Suppl 1:3-6.

Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.

J Clin Psychopharmacol. 1994 Apr;14(2):90-8.

Pharmacokinetics of the newer antidepressants.

Am J Med. 1996 Jan;100(1):119-21. doi: 10.1016/s0002-9343(96)90021-2.

Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?

Int Clin Psychopharmacol. 1995 Jan;9 Suppl 4:27-31.

Effects of imipramine and sertraline on protein kinase activity in rat frontal cortex.

Eur J Pharmacol. 1998 Jan 19;342(1):51-4. doi: 10.1016/s0014-2999(97)01530-6.

引用本文的文献

PharmGKB summary: sertraline pathway, pharmacokinetics.

Pharmacogenet Genomics. 2020 Feb;30(2):26-33. doi: 10.1097/FPC.0000000000000392.

Clinical pharmacokinetics of drugs used to treat urge incontinence.

Clin Pharmacokinet. 2003;42(14):1243-85. doi: 10.2165/00003088-200342140-00004.

Clinical pharmacokinetics of sertraline.

Clin Pharmacokinet. 2002;41(15):1247-66. doi: 10.2165/00003088-200241150-00002.

Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression.

Drug Saf. 1998 Dec;19(6):455-64. doi: 10.2165/00002018-199819060-00003.

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Clin Pharmacokinet. 1997 Dec;33(6):454-71. doi: 10.2165/00003088-199733060-00004.

Drug interactions of clinical significance with selective serotonin reuptake inhibitors.

Drug Saf. 1997 Dec;17(6):390-406. doi: 10.2165/00002018-199717060-00005.

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Clin Pharmacokinet. 1996 Dec;31(6):444-69. doi: 10.2165/00003088-199631060-00004.

Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.

Clin Pharmacokinet. 1995;29 Suppl 1:10-8; discussion 18-9. doi: 10.2165/00003088-199500291-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验